Tissue Engineered Collagen Biomaterials Market: Snapshot
Tissue engineered collagen biomaterials are widely used in plethora of applications. Dental, pharmacological, and medical are some of the key sectors to mention. These materials are uses in many purposes such as orthopedic and wound care. It also holds use as a carrier in drugs administration. By source, tissue engineered collagen biomaterials market can be segmented into porcine, bovine, chicken, marine, and others.
The growth of the global tissue engineered collagen biomaterials market is estimated to be fueled during forecast period by rising use of collagen in healthcare sector, specifically in regenerative medicine.
Increased Demand in Healthcare Sector Spurring Market Growth
Use of collagen as a substitute to bone is rising in recent years. This shift is triggering the tissue engineered collagen biomaterials market. Collagen has diverse properties. It helps in stimulating in tissue growth. It is also found to be useful as a relieving substance in various tissue and bone injuries. Growing inclination toward use of collagen in wound healing process is another major element stimulating the demand for these products. In recent time, there is tremendous rise in number of worldwide population with health issues such as low bone mass and osteoporosis. Rising demand for tissue engineered collagen biomaterials has stimulated the market growth. Besides, growing older population all across the world is expected to open new avenues for global tissue engineered collagen biomaterials market growth.
Growing Business Strategies by Players Widening Market Sphere
Major players in the global tissue engineered collagen biomaterials market are chasing diverse strategic moves such as mergers and acquisitions. Besides, they are heavily investing in research and development activities. The key motive of this move is to improve usability of collagen in diverse medical applications. All these moves are helping them to strengthen their position in the market.
Global Tissue Engineered Collagen Biomaterials Market: Snapshot
Mergers, acquisitions, and distribution agreements are some of the methods leveraged by success-hungry players in the global tissue engineered collagen biomaterials market in order to grow their shares. One of the prominent manufacturers Medtronic, for instance, acquired Covidien, a global healthcare products company, in January 2016 to gain greater stronghold in the global medical device industry.
The global tissue engineered collagen biomaterials market has been majorly fuelled by the extensive research and development activities in regenerative medicine and rising use of collagen as bone substitutes. Another growth driver in the market is the use of collagen in wound healing which offers numerous benefits in terms of stimulating tissue growth and ensuring relief for a variety of injuries on bones and tissues.
On the flipside, however, non-rigidity, potential for antigenicity through telopeptides and collagen materials have the potential to cause cell behavior alteration. This is serving to act as a deterrent to the global tissue engineered collagen biomaterials market. In addition, the transmission of lethal diseases such as mad-cow disease and bird flu, and growing number of government regulations for quality assurance of animal derived products are also negatively impacting the market.
A report by Transparency Market Research forecasts the global tissue engineered collagen biomaterial market to rise at a solid CAGR of 10.4% from 2017 to 2025 to become worth US$5.4 bn in 2025 from US$ 2.2 bn in 2016.
Wound Care Application Segment to Rise at Maximum Pace Owing to Rising Burn Injuries in U.S.
The global tissue engineered collagen biomaterial market can be segmented depending upon application into orthopedics and wound care, among others. The orthopedics segment, at present, leads with maximum market share due to the numerous applications in bone, tendon, and ligament injuries of collagen. As per a report by the National Osteoporosis Foundation in 2014, about 54 million people over 50 years of age in the U.S. are affected by low bone mass and osteoporosis and this has helped catalyze growth in the market.
The wound care segment trails the orthopedics segment in terms of market share and going forward, is expected to register a strong growth pace. According to the American Burn Association (ABA), about a million burn injuries occurs annually in the U.S. and nearly 4,500 patient succumb to it.
Burgeoning Geriatric Population Propels Growth in Asia Pacific Market
Geographically, North America is a market leader that is expected to retain its dominant position in the years ahead as well. A solid manufacturing infrastructure, increasing collagen applications across various industries, and growing thrust on research to develop unique solutions for tissue engineering leading to emergence of many collagen-based products, will likely boost growth in the market. The North America market is slated to become worth US$17 bn by 2025 by clocking a CAGR of 10.0%.
In terms of growth rate, however, Asia Pacific is anticipated to outshine all other regions by registering a solid CAGR of 11.1% from 2017 to 2025. A burgeoning geriatric population and the increasing instances of chronic diseases are said to be driving growth in the region. Growing uptake of advanced wound care products by healthcare professionals and favorable government reimbursement policies are also serving to bolster the tissue engineered collagen biomaterials market in Asia Pacific.
Some of the prominent participants operating in the global tissue engineered collagen biomaterials market are Collagen Matrix Inc., Medtronic, Advanced BioMatrix Inc., Kyeron B.V., Collagen Matrix, Collagen Solutions Plc., CollPlant Ltd., Fraunhofer-Gesellschaft, GENOSS Co., Ltd., and Maxigen Biotech Inc.
|
by Source |
|
|
by Application |
|
|
by Geography |
|
1 Preface
1.1 Market Definition and Scope
1.2 Market Segmentation
1.3 Key Research Objectives
1.4 Research Highlights
2 Assumptions and Research Methodology
3 Executive Summary: Global Tissue Engineered Collagen Biomaterials Market
4 Market Overview
4.1 Introduction
4.1.1 Product Overview
4.1.2 Industry Evolution / Developments
4.1.3 Key Market Indicators
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunity
4.3 Market Revenue Projections
4.4 Porter’s Five Force Analysis
4.5 Value Chain Analysis
4.6 Market Outlook
5 Global Tissue Engineered Collagen Biomaterials Market Analysis and Forecasts, by Source
5.1 Key Findings / Developments
5.2 Introduction & Definition
5.3 Market Value Forecast by Source, 2017–2025
5.3.1 Bovine
5.3.2 Porcine
5.3.3 Marine
5.3.4 Chicken
5.3.5 Others
5.4 Key Trends
5.5 Market Attractiveness by Source
6 Global Tissue Engineered Collagen Biomaterials Market Analysis and Forecasts, by Application
6.1 Key Findings / Developments
6.2 Introduction & Definition
6.3 Market Value Forecast by Application, 2017–2025
6.3.1 Orthopedic
6.3.2 Wound Care
6.3.3 Others
6.4 Key Trends
6.5 Market Attractiveness by Application
7 Global Tissue Engineered Collagen Biomaterials Market Analysis and Forecasts, by Region
7.1 Global Tissue Engineered Collagen Biomaterial Market Snapshot, by Country
7.2 Introduction
7.3 Global Tissue Engineered Collagen Biomaterial Market Forecast By Region
7.4 Global Tissue Engineered Collagen Biomaterial Market Attractiveness Analysis, By Region
7.5 Key Insights
8 North America Tissue Engineered Collagen Biomaterials Market Analysis and Forecasts
8.1 North America Market Value Share Analysis, By Country
8.2 North America Market Forecast By Country
8.3 North America Market Forecast By Source
8.4 North America Market Forecast By Application
8.5 North America Market Attractiveness Analysis
9 Europe Tissue Engineered Collagen Biomaterials Market Analysis and Forecasts
9.1 Europe Market Value Share Analysis, By Country
9.2 Europe Market Forecast By Country
9.3 Europe Market Forecast By Source
9.4 Europe Market Forecast By Application
9.5 Europe Market Attractiveness Analysis
10 Asia Pacific Tissue Engineered Collagen Biomaterials Market Analysis and Forecasts
10.1 Asia Pacific Market Value Share Analysis, By Country
10.2 Asia Pacific Market Forecast By Country
10.3 Asia Pacific Market Forecast By Source
10.4 Asia Pacific Market Forecast By Application
10.5 Asia Pacfic Market Attractiveness Analysis
11 Latin America Tissue Engineered Collagen Biomaterials Market Analysis and Forecasts
11.1 Latin America Market Value Share Analysis, By Country
11.2 Latin America Market Forecast By Country
11.3 Latin America Market Forecast By Source
11.4 Latin America Market Forecast By Application
11.5 Latin America Market Attractiveness Analysis
12 Middle East & Africa (MEA) Tissue Engineered Collagen Biomaterials Market Analysis and Forecasts
12.1 MEA Value Share Analysis, By Country
12.2 MEA Market Forecast By Country
12.3 MEA Market Forecast By Source
12.4 MEA Market Forecast By Application
12.5 MEA Market Attractiveness Analysis
13 Competitive Landscape
13.1 Competition Matrix
13.2 Tissue Engineered Collagen Biomaterials Market: Heat Map Analysis By Company
13.3 Company Profiles
13.3.1 Advanced BioMatrix Inc.
13.3.1.1 Company Details
13.3.1.2 Company Description
13.3.1.3 Business Overview
13.3.1.4 SWOT Analysis
13.3.1.5 Financial Analysis
13.3.1.6 Strategic Overview
13.3.2 Collagen Matrix Inc.
13.3.2.1 Company Details
13.3.2.2 Company Description
13.3.2.3 Business Overview
13.3.2.4 SWOT Analysis
13.3.2.5 Financial Analysis
13.3.2.6 Strategic Overview
13.3.3 CollPlant Ltd.
13.3.3.1 Company Details
13.3.3.2 Company Description
13.3.3.3 Business Overview
13.3.3.4 SWOT Analysis
13.3.3.5 Financial Analysis
13.3.3.6 Strategic Overview
13.3.4 Collagen Matrix
13.3.4.1 Company Details
13.3.4.2 Company Description
13.3.4.3 Business Overview
13.3.4.4 SWOT Analysis
13.3.4.5 Financial Analysis
13.3.4.6 Strategic Overview
13.3.5 Collagen Solutions Plc.
13.3.5.1 Company Details
13.3.5.2 Company Description
13.3.5.3 Business Overview
13.3.5.4 SWOT Analysis
13.3.5.5 Financial Analysis
13.3.5.6 Strategic Overview
13.3.6 Fraunhofer-Gesellschaft
13.3.6.1 Company Details
13.3.6.2 Company Description
13.3.6.3 Business Overview
13.3.6.4 SWOT Analysis
13.3.6.5 Financial Analysis
13.3.6.6 Strategic Overview
13.3.7 GENOSS Co., Ltd.
13.3.7.1 Company Details
13.3.7.2 Company Description
13.3.7.3 Business Overview
13.3.7.4 SWOT Analysis
13.3.7.5 Financial Analysis
13.3.7.6 Strategic Overview
13.3.8 Kyeron B.V.
13.3.8.1 Company Details
13.3.8.2 Company Description
13.3.8.3 Business Overview
13.3.8.4 SWOT Analysis
13.3.8.5 Financial Analysis
13.3.8.6 Strategic Overview
13.3.9 Maxigen Biotech Inc.
13.3.9.1 Company Details
13.3.9.2 Company Description
13.3.9.3 Business Overview
13.3.9.4 SWOT Analysis
13.3.9.5 Financial Analysis
13.3.9.6 Strategic Overview
13.3.10 Medtronic
13.3.10.1 Company Details
13.3.10.2 Company Description
13.3.10.3 Business Overview
13.3.10.4 SWOT Analysis
13.3.10.5 Financial Analysis
13.3.10.6 Strategic Overview
List of Tables
Table 1: Global Tissue Engineered Collagen Biomaterials Market Size (US$ Mn) Forecast, by Sources, 2015–2025
Table 2: Global Tissue Engineered Collagen Biomaterials Market Size (US$ Mn) Forecast, by Applications, 2015–2025
Table 3: Global Tissue Engineered Collagen Biomaterials Market Volume (Million Units) Forecast, by Applications, 2015–2025
Table 4: Global Tissue Engineered Collagen Biomaterials Market Size (US$ Mn) Forecast, by Region, 2015–2025
Table 5: North America Tissue Engineered Collagen Biomaterial Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 6: North America Tissue Engineered Collagen Biomaterial Market Size (US$ Mn) Forecast, by Source, 2015–2025
Table 7: North America Tissue Engineered Collagen Biomaterial Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 8: Europe Tissue Engineered Collagen Biomaterial Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 9: Europe Tissue Engineered Collagen Biomaterial Market Size (US$ Mn) Forecast, by Source, 2015–2025
Table 10: Europe Tissue Engineered Collagen Biomaterial Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 11: Asia Pacific Tissue Engineered Collagen Biomaterial Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 12: Asia Pacific Tissue Engineered Collagen Biomaterial Market Size (US$ Mn) Forecast, by Source, 2015–2025
Table 13: Asia Pacific Tissue Engineered Collagen Biomaterial Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 14: Latin America Tissue Engineered Collagen Biomaterial Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 15: Latin America Tissue Engineered Collagen Biomaterial Market Size (US$ Mn) Forecast, by Source, 2015–2025
Table 16: Latin America Tissue Engineered Collagen Biomaterial Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 17: Middle East & Africa Tissue Engineered Collagen Biomaterial Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 18: Middle East & Africa Tissue Engineered Collagen Biomaterial Market Size (US$ Mn) Forecast, by Source, 2015–2025
Table 19: Middle East & Africa Tissue Engineered Collagen Biomaterial Market Size (US$ Mn) Forecast, by Application, 2015–2025
List of Figures
Figure 1: Global Tissue Engineered Collagen Biomaterials Market Size, by Sources (US$ Mn), 2016
Figure 2: Global Tissue Engineered Collagen Biomaterials Market Value (US$ Mn), 2016
Figure 3: Revenue Share, 2016
Figure 4: Key Industry Events
Figure 5: Tissue Engineered Collagen Biomaterials Market: Porter’s Five Force Analysis
Figure 6: Value Chain Analysis: Global Tissue Engineered Collagen Biomaterial Market
Figure 7: Global Tissue Engineered Collagen Biomaterial Market Size (US$ Mn) Forecast, 2015–2025
Figure 8: Market Value Share, by Source (2016)
Figure 9: Market Value Share, by Application (2016)
Figure 10: Market Value Share, by Region (2016)
Figure 11: Global Tissue Engineered Collagen Biomaterials Market Value Share Analysis, by Sources, 2017 and 2025
Figure 12: Global Tissue Engineered Collagen Biomaterials Market Attractiveness Analysis, by Sources, 2017–2025
Figure 13: Global Tissue Engineered Collagen Biomaterials Market Forecast, by Sources Marine, Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 14: Global Tissue Engineered Collagen Biomaterials Market Forecast, by Sources Bovine, Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 15: Global Tissue Engineered Collagen Biomaterials Market Forecast, by Sources Porcine, Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 16: Global Tissue Engineered Collagen Biomaterials Market Forecast, by Sources Chicken, Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 17: Global Tissue Engineered Collagen Biomaterials Market Forecast, by Other Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 18: Global Tissue Engineered Collagen Biomaterials Market Value Share Analysis, by Applications, 2017 and 2025
Figure 19: Global Tissue Engineered Collagen Biomaterials Market Attractiveness Analysis, by Applications, 2017–2025
Figure 20: Global Tissue Engineered Collagen Biomaterials Market Forecast, by Applications Wound Care, Market Revenue (US$ Mn) and Volume, 2015–2025
Figure 21: Global Tissue Engineered Collagen Biomaterials Market Forecast, by Applications Orthopedics, Market Revenue (US$ Mn) and Volume, 2015–2025
Figure 22: Global Tissue Engineered Collagen Biomaterials Market Forecast, by Other Market Revenue (US$ Mn) and Volume, 2015–2025
Figure 23: Global Tissue Engineered Collagen Biomaterials Market Value Share Analysis, by Region, 2017 and 2025
Figure 24: Global Tissue Engineered Collagen Biomaterials Market Attractiveness Analysis, by Region, 2017–2025
Figure 25: North America Tissue Engineered Collagen Biomaterial Market Value Share Analysis, by Country, 2017 and2025
Figure 26: North America Tissue Engineered Collagen Biomaterial Market Attractiveness Analysis, by Country, 2017-2025
Figure 27: North America Tissue Engineered Collagen Biomaterial Market Value Share Analysis, by Source, 2017 and 2025
Figure 28: North America Tissue Engineered Collagen Biomaterial Market Value Share Analysis, by Application, 2017 and 2025
Figure 29: North America Tissue Engineered Collagen Biomaterial Market Attractiveness Analysis, by Source, 2017-2025
Figure 30: North America Tissue Engineered Collagen Biomaterial Market Attractiveness Analysis, by Application, 2017–2025
Figure 31: Europe Tissue Engineered Collagen Biomaterial Market Value Share Analysis, by Country, 2017 and 2025
Figure 32: Europe Tissue Engineered Collagen Biomaterial Market Attractiveness Analysis, by Country, 2017-2025
Figure 33: Europe Tissue Engineered Collagen Biomaterial Market Value Share Analysis, by Source, 2017 and 2025
Figure 34: Europe Tissue Engineered Collagen Biomaterial Market Value Share Analysis, by Application, 2017 and 2025
Figure 35: Europe Tissue Engineered Collagen Biomaterial Market Attractiveness Analysis, by Source, 2017-2025
Figure 36: Europe Tissue Engineered Collagen Biomaterial Market Attractiveness Analysis, by Application, 2017-2025
Figure 37: Asia Pacific Tissue Engineered Collagen Biomaterial Market Value Share Analysis, by Country, 2017 and 2025
Figure 38: Asia Pacific Tissue Engineered Collagen Biomaterial Market Attractiveness Analysis, by Country, 2017-2025
Figure 39: Asia Pacific Tissue Engineered Collagen Biomaterial Market Value Share Analysis, by Source, 2017 and 2025
Figure 40: Asia Pacific Tissue Engineered Collagen Biomaterial Market Value Share Analysis, by Application, 2017 and 2025
Figure 41: Asia Pacific Tissue Engineered Collagen Biomaterial Market Attractiveness Analysis, by Source, 2017-2025
Figure 42: Asia Pacific Tissue Engineered Collagen Biomaterial Market Attractiveness Analysis, by Application, 2017-2025
Figure 43: Latin America Tissue Engineered Collagen Biomaterial Market Value Share Analysis, by Country, 2017 and 2025
Figure 44: Latin America Tissue Engineered Collagen Biomaterial Market Attractiveness Analysis, by Country, 2017-2025
Figure 45: Latin America Tissue Engineered Collagen Biomaterial Market Value Share Analysis, by Source, 2017 and 2025
Figure 46: Latin America Tissue Engineered Collagen Biomaterial Market Value Share Analysis, by Application, 2017 and 2025
Figure 47: Latin America Tissue Engineered Collagen Biomaterial Market Attractiveness Analysis, by Source, 2017-2025
Figure 48: Latin America Tissue Engineered Collagen Biomaterial Market Attractiveness Analysis, by Application, 2017-2025
Figure 49: Middle East & Africa Tissue Engineered Collagen Biomaterial Market Value Share Analysis, by Country, 2017 and 2025
Figure 50: Middle East & Africa Tissue Engineered Collagen Biomaterial Market Attractiveness Analysis, by Country, 2017-2025
Figure 51: Middle East & Africa Tissue Engineered Collagen Biomaterial Market Value Share Analysis, by Source, 2017 and 2025
Figure 52: Middle East & Africa Tissue Engineered Collagen Biomaterial Market Value Share Analysis, by Application, 2017 and 2025
Figure 53: Middle East & Africa Tissue Engineered Collagen Biomaterial Market Attractiveness Analysis, by Source, 2017-2025
Figure 54: Middle East & Africa Tissue Engineered Collagen Biomaterial Market Attractiveness Analysis, by Source, 2017-2025
Figure 55: Tissue Engineered Collagen Biomaterials Market: Heat Map Analysis by Company (2016)
Figure 56: Collagen Solution plc, Breakdown of Net Sales, by Region, 2016
Figure 57: Collagen Solution plc, Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2016
Figure 58: CollPlant Ltd., Product Development Events and recognition
Figure 59: CollPlant Ltd., Management List
Figure 60: Medtronic, Breakdown of Net Sales, by Region, 2016
Figure 61: Medtronic, Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2016
Figure 62: Advanced BioMatrix, Inc., Distributors geographical presence
Figure 63: Advanced BioMatrix, Inc., Core Capabilities
Figure 64: Olympus Terumo Biomaterials Corp, Breakdown of Net Sales, by Region, 2016
Figure 65: Olympus Terumo Biomaterials Corp, Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2016
Figure 66: Fraunhofer-Gesellschaft, Subsidiaries are Present in the Following Countries
Figure 67: Fraunhofer-Gesellschaft, Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2016
Figure 68: Collagen Matrix Inc., Adopted technology for Collagen Formation
Figure 69: Collagen Matrix Inc., Key Management
Figure 70: KYERON, Recent Achievements
Figure 71: KYERON, Recent Approvals
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Tissue Engineered Collagen Biomaterials Market
